TCM
Tekla Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-30,590
| Closed | -$3.42M | – | 214 |
|
|
2020
Q2 | $3.42M | Hold |
30,590
| – | – | 0.13% | 128 |
|
|
2020
Q1 | $2.23M | Sell |
30,590
-10,365
| -25% | -$754K | 0.1% | 129 |
|
|
2019
Q4 | $4.27M | Sell |
40,955
-3,100
| -7% | -$323K | 0.16% | 119 |
|
|
2019
Q3 | $4.39M | Hold |
44,055
| – | – | 0.19% | 89 |
|
|
2019
Q2 | $5.03M | Buy |
44,055
+14,160
| +47% | +$1.62M | 0.21% | 90 |
|
|
2019
Q1 | $3.76M | Buy |
29,895
+3,445
| +13% | +$433K | 0.15% | 109 |
|
|
2018
Q4 | $3.59M | Buy |
26,450
+17,510
| +196% | +$2.38M | 0.15% | 101 |
|
|
2018
Q3 | $2.45M | Buy |
+8,940
| New | +$2.45M | 0.09% | 136 |
|
|
2015
Q1 | – | Sell |
-69,200
| Closed | -$3.68M | – | 102 |
|
|
2014
Q4 | $3.68M | Hold |
69,200
| – | – | 0.17% | 77 |
|
|
2014
Q3 | $3.25M | Buy |
+69,200
| New | +$3.25M | 0.15% | 85 |
|